{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:28Z","timestamp":1792787308263,"version":"4.5.0"},"reference-count":57,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Tumor Measurement Initiative through the MD Anderson Strategic Initiative Development Program","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"CPRIT","award":["RP240117"],"award-info":[{"award-number":["RP240117"]}],"id":[{"id":"https:\/\/ror.org\/0003xa228","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Permanent Health Funds","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"MD Anderson Cancer Center Support","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}]},{"name":"Philanthropic contributions from Mrs. Andrea Mugnaini and Dr. Edward L.C. Smith","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The University of Texas MD Anderson Lung Moon Shot Program","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"National Institutes of Health","award":["R01CA262425"],"award-info":[{"award-number":["R01CA262425"]}]},{"name":"National Institutes of Health","award":["R01CA276178"],"award-info":[{"award-number":["R01CA276178"]}]},{"name":"Rexanna\u2019s Foundation for Fighting Lung Cancer","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"https:\/\/ror.org\/02kp3kh50","id-type":"ROR","asserted-by":"crossref"}]},{"name":"QIAC Partnership in Research","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,9,1]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, but can cause serious immune-related adverse events, with pneumonitis (ICI-P) being among the most severe. Early identification of high-risk patients before ICI initiation is critical for close monitoring, timely intervention, and optimizing outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To develop and validate a deep learning foundation model to predict ICI-P from baseline CT scans in patients with lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We designed the Checkpoint-Inhibitor Pneumonitis Hazard EstimatoR (CIPHER), a deep learning-powered foundation model combining contrastive learning with a transformer-based masked autoencoder to predict ICI-P from baseline CT scans in patients with lung cancer. Using self-supervised learning, CIPHER was pretrained on 590,284 CT slices from 2,500 patients with non-small cell lung cancer (NSCLC) to learn representations of heterogeneous lung parenchyma. Following pretraining, CIPHER was adapted to the internal MD Anderson Cancer Center NSCLC immunotherapy cohort of 347 patients, of whom 33 developed adjudicated ICI-P. Fine-tuning was performed using 254 non-ICI-P patients only, and a held-out internal validation set of 93 patients, including 33 ICI-P cases and 60 non-ICI-P controls, was reserved for evaluation. CIPHER was benchmarked against clinical, radiomics, and ensemble comparator models and externally validated in an independent Johns Hopkins NSCLC cohort of 116 patients, including 20 ICI-P cases and 96 non-ICI-P controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In our internal immunotherapy cohort, CIPHER consistently distinguished patients at elevated risk of ICI-P from those without the event, with area under the curves (AUCs) ranging from 0.77 to 0.85. In head-to-head benchmarking, CIPHER achieved an AUC of 0.83, outperforming the clinical, radiomics and ensemble models. In the external validation cohort, CIPHER maintained high performance (AUC=0.83; balanced accuracy=81.7%), exceeding the radiomics model (DeLong p=0.0318) and demonstrating superior specificity without sacrificing sensitivity. By contrast, the radiomics model, despite high sensitivity (85.0%), showed markedly lower specificity (45.8%). Confusion matrix analyses confirmed CIPHER\u2019s robust classification, correctly identifying 80 of 96 non-ICI-P cases and 16 of 20 ICI-P cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We developed and externally validated CIPHER, a CT-based imaging biomarker for pretreatment ICI-P risk stratification in NSCLC. CIPHER shows promise as a non-invasive tool for ICI-P risk assessment but warrants prospective validation before clinical translation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2026-015014","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:20:18Z","timestamp":1789737618000},"page":"e015014","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["CT-based deep foundation model for predicting immune checkpoint inhibitor-induced pneumonitis risk in lung cancer"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7157-3020","authenticated-orcid":false,"given":"Amgad","family":"Muneer","sequence":"first","affiliation":[{"name":"Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Showkatian","sequence":"additional","affiliation":[{"name":"Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Kitsel","sequence":"additional","affiliation":[{"name":"Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"},{"name":"Department of Thoracic\/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliazurina B","family":"Saad","sequence":"additional","affiliation":[{"name":"Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheeba J","family":"Sujit","sequence":"additional","affiliation":[{"name":"Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2126-8316","authenticated-orcid":false,"given":"Felipe","family":"Soto","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish S","family":"Shroff","sequence":"additional","affiliation":[{"name":"Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-3945","authenticated-orcid":false,"given":"Saadia A","family":"Faiz","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad I","family":"Ghanbar","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4578-9437","authenticated-orcid":false,"given":"Sherif M","family":"Ismail","sequence":"additional","affiliation":[{"name":"Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3766-5335","authenticated-orcid":false,"given":"Natalie I","family":"Vokes","sequence":"additional","affiliation":[{"name":"Department of Thoracic\/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3008-5407","authenticated-orcid":false,"given":"Tina","family":"Cascone","sequence":"additional","affiliation":[{"name":"Department of Thoracic\/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuning","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Thoracic\/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-3477","authenticated-orcid":false,"given":"Jianjun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic\/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A","family":"Byers","sequence":"additional","affiliation":[{"name":"Department of Thoracic\/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jaffray","sequence":"additional","affiliation":[{"name":"Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"},{"name":"Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8435-2083","authenticated-orcid":false,"given":"Joe Y","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxing","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-8513","authenticated-orcid":false,"given":"Aung","family":"Naing","sequence":"additional","affiliation":[{"name":"Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don L","family":"Gibbons","sequence":"additional","affiliation":[{"name":"Department of Thoracic\/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ara A","family":"Vaporciyan","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V","family":"Heymach","sequence":"additional","affiliation":[{"name":"Department of Thoracic\/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Suresh","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9229-156X","authenticated-orcid":false,"given":"Mehmet","family":"Altan","sequence":"additional","affiliation":[{"name":"Department of Thoracic\/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-0180","authenticated-orcid":false,"given":"Ajay","family":"Sheshadri","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8392-8338","authenticated-orcid":false,"given":"Jia","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"},{"name":"Department of Thoracic\/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"},{"name":"Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2026091806201239000_14.9.e015014.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00577-5"},{"key":"2026091806201239000_14.9.e015014.2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08114-x"},{"key":"2026091806201239000_14.9.e015014.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.05.029"},{"key":"2026091806201239000_14.9.e015014.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-024-12315-5","article-title":"Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with driver-gene negative advanced non-small cell lung cancer","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer"},{"key":"2026091806201239000_14.9.e015014.5","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-022-00515-z"},{"key":"2026091806201239000_14.9.e015014.6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/jamaoncol.2022.5389","article-title":"Perioperative Immune Checkpoint Inhibition in Early-Stage Non-Small Cell Lung Cancer: A Review","volume":"9","author":"Desai","year":"2023","journal-title":"JAMA Oncol"},{"key":"2026091806201239000_14.9.e015014.7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0416","article-title":"A Comparison of Response Patterns for Progression-Free Survival and Overall Survival Following Treatment for Cancer With PD-1 Inhibitors: A Meta-analysis of Correlation and Differences in Effect Sizes","volume":"1","author":"Gyawali","year":"2018","journal-title":"JAMA Netw Open"},{"key":"2026091806201239000_14.9.e015014.8","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1001\/jamaoncol.2016.1051","article-title":"Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review","volume":"2","author":"Friedman","year":"2016","journal-title":"JAMA Oncol"},{"key":"2026091806201239000_14.9.e015014.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00615-z"},{"key":"2026091806201239000_14.9.e015014.10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","article-title":"Immune-related adverse events of checkpoint inhibitors","volume":"6","author":"Ramos-Casals","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026091806201239000_14.9.e015014.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0352-8"},{"key":"2026091806201239000_14.9.e015014.12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.743582","article-title":"Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer","volume":"12","author":"Rapoport","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026091806201239000_14.9.e015014.13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jtho.2023.11.018","article-title":"Immune-Related Toxicity in NSCLC: Current State-of-the-Art and Emerging Clinical Challenges","volume":"19","author":"O\u2019Leary","year":"2024","journal-title":"J Thorac Oncol"},{"key":"2026091806201239000_14.9.e015014.14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.chest.2021.02.032","article-title":"Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer: Real-World Incidence, Risk Factors, and Management Practices Across Six Health Care Centers in North Carolina","volume":"160","author":"Atchley","year":"2021","journal-title":"Chest"},{"key":"2026091806201239000_14.9.e015014.15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cllc.2024.07.017","article-title":"Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis","volume":"25","author":"Soto-Lanza","year":"2024","journal-title":"Clin Lung Cancer"},{"key":"2026091806201239000_14.9.e015014.16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.52302","article-title":"Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors","volume":"7","author":"Cook","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026091806201239000_14.9.e015014.17","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-022-02127-3","article-title":"Establishment and validation of nomogram for predicting immuno checkpoint inhibitor related pneumonia","volume":"22","author":"Li","year":"2022","journal-title":"BMC Pulm Med"},{"key":"2026091806201239000_14.9.e015014.18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1138489","article-title":"Identification and prediction of immune checkpoint inhibitors-related pneumonitis by machine learning","volume":"14","author":"Gong","year":"2023","journal-title":"Front Immunol"},{"key":"2026091806201239000_14.9.e015014.19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70743-2","article-title":"Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study","volume":"10","author":"Okada","year":"2020","journal-title":"Sci Rep"},{"key":"2026091806201239000_14.9.e015014.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02805-4"},{"key":"2026091806201239000_14.9.e015014.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.12.656"},{"key":"2026091806201239000_14.9.e015014.22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.22906","article-title":"Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor-Induced Interstitial Lung Disease Among Patients With Nonlung Cancers","volume":"3","author":"Shimoji","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026091806201239000_14.9.e015014.23","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021203427"},{"key":"2026091806201239000_14.9.e015014.24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1320"},{"key":"2026091806201239000_14.9.e015014.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1505197"},{"key":"2026091806201239000_14.9.e015014.26","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/S2589-7500(23)00082-1","article-title":"Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study","volume":"5","author":"Saad","year":"2023","journal-title":"Lancet Digit Health"},{"key":"2026091806201239000_14.9.e015014.27","doi-asserted-by":"crossref","first-page":"e1065","DOI":"10.1093\/oncolo\/oyad118","article-title":"Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience","volume":"28","author":"Altan","year":"2023","journal-title":"Oncologist"},{"key":"2026091806201239000_14.9.e015014.28","doi-asserted-by":"crossref","DOI":"10.1186\/s41747-020-00173-2","article-title":"Automatic lung segmentation in routine imaging is primarily a data diversity problem, not a methodology problem","volume":"4","author":"Hofmanninger","year":"2020","journal-title":"Eur Radiol Exp"},{"key":"2026091806201239000_14.9.e015014.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05881-4"},{"key":"2026091806201239000_14.9.e015014.30","doi-asserted-by":"crossref","unstructured":"Azizi S , Mustafa B , Ryan F , et al . Big self-supervised models advance medical image classification. 2021 IEEE\/CVF International Conference on Computer Vision (ICCV); 3478\u201388. Montreal, QC, Canada. doi:10.1109\/ICCV48922.2021.00346","DOI":"10.1109\/ICCV48922.2021.00346"},{"key":"2026091806201239000_14.9.e015014.31","doi-asserted-by":"crossref","unstructured":"He K , Chen X , Xie S , et al . Masked autoencoders are scalable vision learners. 2022 IEEE\/CVF Conference on Computer Vision and Pattern Recognition (CVPR); 16000\u20139. New Orleans, LA, USA. doi:10.1109\/CVPR52688.2022.01553","DOI":"10.1109\/CVPR52688.2022.01553"},{"key":"2026091806201239000_14.9.e015014.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2023.102802"},{"key":"2026091806201239000_14.9.e015014.33","unstructured":"Erickson N , Mueller J , Shirkov A , et al . Autogluon-tabular: Robust and accurate automl for structured data. arXiv Preprint arXiv 2020;200306505."},{"key":"2026091806201239000_14.9.e015014.34","doi-asserted-by":"crossref","unstructured":"Devi D , Biswas SK , Purkayastha B . A review on solution to class imbalance problem: undersampling approaches. 2020 International Conference on Computational Performance Evaluation (ComPE); IEEE, 626\u201331. Shillong, India. doi:10.1109\/ComPE49325.2020.9200087 Available: https:\/\/ieeexplore.ieee.org\/xpl\/mostRecentIssue.jsp?punumber=9199029","DOI":"10.1109\/ComPE49325.2020.9200087"},{"key":"2026091806201239000_14.9.e015014.35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1159\/000543556","article-title":"Characteristics and Risk Factors of Immune Checkpoint Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer: A Retrospective Study","volume":"103","author":"Cui","year":"2025","journal-title":"Oncology"},{"key":"2026091806201239000_14.9.e015014.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2018.09.015"},{"key":"2026091806201239000_14.9.e015014.37","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001754","article-title":"Strategies for improving the management of immune-related adverse events","volume":"8","author":"Naing","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2026091806201239000_14.9.e015014.38","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1016\/S1470-2045(20)30107-8","article-title":"Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research","volume":"21","author":"Johnson","year":"2020","journal-title":"Lancet Oncol"},{"key":"2026091806201239000_14.9.e015014.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2022.12.013"},{"key":"2026091806201239000_14.9.e015014.40","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.acra.2023.10.039","article-title":"Development and Validation of a Machine Learning\u2013Based Model Using CT Radiomics for Predicting Immune Checkpoint Inhibitor-related Pneumonitis in Patients With NSCLC Receiving Anti-PD1 Immunotherapy: A Multicenter Retrospective Case Control Study","volume":"31","author":"Zhang","year":"2024","journal-title":"Acad Radiol"},{"key":"2026091806201239000_14.9.e015014.41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040652","article-title":"Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis","volume":"13","author":"Mallio","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026091806201239000_14.9.e015014.42","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.978222","article-title":"Deep learning predicts immune checkpoint inhibitor-related pneumonitis from pretreatment computed tomography images","volume":"13","author":"Tan","year":"2022","journal-title":"Front Physiol"},{"key":"2026091806201239000_14.9.e015014.43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95643-x","article-title":"Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis","volume":"11","author":"Kawahara","year":"2021","journal-title":"Sci Rep"},{"key":"2026091806201239000_14.9.e015014.44","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.2022.40.16_suppl.2580","article-title":"Radiotherapy-immunotherapy related pneumonitis prediction from pre-treatment CT using a deep graph-based integrative model","volume":"40","author":"Yang","year":"2022","journal-title":"JCO"},{"key":"2026091806201239000_14.9.e015014.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.01.027"},{"key":"2026091806201239000_14.9.e015014.46","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.acra.2024.09.053","article-title":"Radiomics Biomarkers to Predict Checkpoint Inhibitor Pneumonitis in Non-small Cell Lung Cancer","volume":"32","author":"Du","year":"2025","journal-title":"Acad Radiol"},{"key":"2026091806201239000_14.9.e015014.47","doi-asserted-by":"crossref","DOI":"10.1177\/15330338251344004","article-title":"Machine Learning Model Integrating CT Radiomics of the Lung to Predict Checkpoint Inhibitor Pneumonitis in Patients with Advanced Cancer","volume":"24","author":"Cousin","year":"2025","journal-title":"Technol Cancer Res Treat"},{"key":"2026091806201239000_14.9.e015014.48","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-025-14628-5","article-title":"Imaging features and prognostic significance of immune checkpoint inhibitor\u2013related pneumonitis in NSCLC","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Cancer"},{"key":"2026091806201239000_14.9.e015014.49","doi-asserted-by":"crossref","DOI":"10.1200\/CCI-24-00198","article-title":"Radiomics and Deep Learning Prediction of Immunotherapy-Induced Pneumonitis From Computed Tomography","volume":"9","author":"Smith","year":"2025","journal-title":"JCO Clin Cancer Inform"},{"key":"2026091806201239000_14.9.e015014.50","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-025-05905-w","article-title":"Clinical features of immune checkpoint inhibitor-related pneumonitis in older patients with lung cancer receiving immune checkpoint inhibitors-based therapy: a retrospective study","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Geriatr"},{"key":"2026091806201239000_14.9.e015014.51","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1596223","article-title":"Prognostic analysis and association of the systemic immune-inflammatory index with immune checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer","volume":"15","author":"Cai","year":"2025","journal-title":"Front Oncol"},{"key":"2026091806201239000_14.9.e015014.52","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71041","article-title":"Heterogeneity of Checkpoint Inhibitor-Associated Pneumonitis: A Multicenter Study on Inflammatory Subtypes and Clinical Outcomes","volume":"14","author":"Luo","year":"2025","journal-title":"Cancer Med"},{"key":"2026091806201239000_14.9.e015014.53","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14124330","article-title":"Radiomics Models to Predict Tumor Response and Pneumonitis in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy","volume":"14","author":"Yadav","year":"2025","journal-title":"J Clin Med"},{"key":"2026091806201239000_14.9.e015014.54","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-017-0524-2"},{"key":"2026091806201239000_14.9.e015014.55","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27561","article-title":"Evaluating the diagnostic and therapeutic significance of KL-6 in patients with interstitial lung diseases","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"2026091806201239000_14.9.e015014.56","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010114","article-title":"Krebs von den Lungen-6 surveillance in immune checkpoint inhibitor-induced pneumonitis","volume":"12","author":"Matsukane","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026091806201239000_14.9.e015014.57","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16111990","article-title":"Is 18F-FDG-PET\/CT an Optimal Imaging Modality for Detecting Immune-Related Adverse Events after Immune-Checkpoint Inhibitor Therapy? Pros and Cons","volume":"16","author":"Karlsen","year":"2024","journal-title":"Cancers (Basel)"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-015014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:20:26Z","timestamp":1789737626000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-015014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,18]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/jitc-2026-015014"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-015014","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}